Intracellular Th

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$175,159
$161,388
$144,866
$131,506
Gross Profit
159,855
150,034
134,966
120,804
EBITDA
-38,849
-27,594
-20,820
-33,961
EBIT
-38,987
-27,723
-20,952
-34,097
Net Income
-26,324
-16,219
-15,247
-28,579
Net Change In Cash
175,159
161,388
144,866
131,506
Free Cash Flow
-27,221
489
-34,116
-2,062
Cash
464,312
695,056
141,569
147,767
Basic Shares
105,768
103,723
96,875
96,285

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$680,852
$464,370
$249,132
$81,707
Gross Profit
623,889
430,625
228,689
73,673
EBITDA
-116,721
-158,853
-262,970
-285,154
EBIT
-159,381
-263,626
-285,688
Net Income
-74,676
-139,674
-256,256
-284,125
Net Change In Cash
680,852
464,370
249,132
81,707
Cost of Revenue
56,600
32,319
Free Cash Flow
-73,499
-124,468
-270,964
-259,869
Cash
306,948
147,767
148,615
92,364
Basic Shares
103,131
95,881
94,046
81,253

Earnings Calls

Quarter EPS
2024-12-31
-$0.16
2024-09-30
-$0.25
2024-06-30
-$0.16
2024-03-31
-$0.16